Embecta Corp. will host a conference call on August 8, 2025, to discuss fiscal Q3 results and operations.
Quiver AI Summary
Embecta Corp., a company noted for its century-long history in insulin delivery, is transitioning to a broader medical supplies focus. On August 8, 2025, at 8:00 a.m. ET, the company will hold a conference call to discuss its fiscal third quarter 2025 financial results, provide an operational update, and facilitate a question and answer session. Participants can join the call via a live webcast or teleconference, with a replay available on the company's investor relations website later that day. Embecta aims to enhance lives through innovative solutions and has around 2,000 employees globally. More details can be found on their website and social media channels.
Potential Positives
- Embecta Corp. is hosting a conference call to discuss its fiscal third quarter 2025 financial results, which indicates a commitment to transparency and communication with investors.
- The company is transitioning to become a broad-based medical supplies company, signaling potential growth opportunities beyond its legacy in insulin delivery.
- Approximately 2,000 employees are involved in the company's mission, highlighting a significant workforce dedicated to innovation and improvement in healthcare solutions.
Potential Negatives
- The press release does not provide any details about the company's financial performance or expectations, which may raise concerns among investors about transparency and financial health.
- There is no mention of any specific challenges or risks the company is facing, which could indicate a lack of preparedness for addressing potential issues.
- The reliance on a legacy of insulin delivery without highlighting current innovations may suggest stagnation or a lack of progress in evolving their product offerings.
FAQ
What is the date and time of the Embecta Corp. conference call?
The Embecta Corp. conference call will be held on August 8, 2025, at 8:00 a.m. Eastern Time (ET).
How can I access the live webcast of the conference call?
The live webcast can be accessed through the company's website or directly via the provided links in the press release.
Will there be a replay of the conference call available?
Yes, a replay of the conference call will be available starting at 11:00 a.m. ET on August 8, 2025, for one year.
What topics will Embecta discuss during the conference call?
Embecta will discuss its fiscal third quarter 2025 financial results and provide an operational update during the call.
How many employees does Embecta have globally?
Embecta has approximately 2,000 employees worldwide, contributing to its mission in medical supplies and insulin delivery.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$EMBC Insider Trading Activity
$EMBC insiders have traded $EMBC stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $EMBC stock by insiders over the last 6 months:
- DAVID F MELCHER has made 2 purchases buying 23,000 shares for an estimated $283,641 and 0 sales.
- MILTON MAYO MORRIS sold 3,100 shares for an estimated $50,782
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EMBC Hedge Fund Activity
We have seen 130 institutional investors add shares of $EMBC stock to their portfolio, and 149 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 1,761,491 shares (-70.7%) from their portfolio in Q1 2025, for an estimated $22,459,010
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 1,238,911 shares (+167.5%) to their portfolio in Q1 2025, for an estimated $15,796,115
- SIO CAPITAL MANAGEMENT, LLC added 682,039 shares (+160.3%) to their portfolio in Q1 2025, for an estimated $8,695,997
- AMERICAN CENTURY COMPANIES INC added 551,477 shares (+16.9%) to their portfolio in Q1 2025, for an estimated $7,031,331
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) removed 550,000 shares (-16.8%) from their portfolio in Q1 2025, for an estimated $7,012,500
- LOOMIS SAYLES & CO L P added 421,230 shares (+inf%) to their portfolio in Q1 2025, for an estimated $5,370,682
- UBS GROUP AG removed 417,457 shares (-52.0%) from their portfolio in Q1 2025, for an estimated $5,322,576
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
PARSIPPANY, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal third quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, August 8, 2025.
Those who would like to participate may access the live webcast here , or access the teleconference here . The live webcast can also be accessed via the company’s website at investors.embecta.com .
A webcast replay of the call will be available beginning at 11:00 a.m. ET on August 8, 2025, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit
embecta.com
or follow our social channels on
LinkedIn
,
Facebook
, and
Instagram
.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
